All references in this report to Corbus, the Company, we, us, or our mean Corbus Pharmaceuticals Holdings, Inc. and its subsidiaries unless we state otherwise, or the context otherwise indicates. Overview Corbus Pharmaceuticals Holdings, Inc. (the Company or Corbus) is a clinical stage company focused on promising new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing innovative scientific approaches to well-understood biological pathways. Cor...
Q2 FY2026 — expected 2026-09-10
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-09 | 2025-12-31 | 0001193125-26-098530 | EDGAR | 71K words |
| 2025-03-11 | 2024-12-31 | 0000950170-25-037335 | EDGAR | — |
| 2024-03-12 | 2023-12-31 | 0000950170-24-030133 | EDGAR | — |
| 2023-03-07 | 2022-12-31 | 0000950170-23-006469 | EDGAR | — |
| 2022-03-08 | 2021-12-31 | 0000950170-22-003145 | EDGAR | — |
| 2021-03-15 | 2020-12-31 | 0001493152-21-006016 | EDGAR | — |
| 2020-03-16 | 2019-12-31 | 0001493152-20-004077 | EDGAR | — |
| 2019-03-12 | 2018-12-31 | 0001493152-19-003143 | EDGAR | — |
| 2018-03-12 | 2017-12-31 | 0001493152-18-003208 | EDGAR | — |
| 2017-03-08 | 2016-12-31 | 0001493152-17-002256 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-06 | 2026-06-30 | 0001193125-26-338274 | EDGAR | — |
| 2025-11-12 | 2025-09-30 | 0001193125-25-277748 | EDGAR | 19K words |
| 2025-08-05 | 2025-06-30 | 0000950170-25-103118 | EDGAR | — |
| 2025-05-06 | 2025-03-31 | 0000950170-25-064507 | EDGAR | — |
| 2024-11-07 | 2024-09-30 | 0000950170-24-123486 | EDGAR | — |
| 2024-08-06 | 2024-06-30 | 0000950170-24-091922 | EDGAR | — |
| 2024-05-07 | 2024-03-31 | 0000950170-24-054625 | EDGAR | — |
| 2023-11-07 | 2023-09-30 | 0000950170-23-060377 | EDGAR | — |
| 2023-08-08 | 2023-06-30 | 0000950170-23-039960 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0000950170-23-019825 | EDGAR | — |
| 2022-11-08 | 2022-09-30 | 0000950170-22-023282 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0000950170-22-016150 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-06 | 0001193125-26-336864 | EDGAR | — |
| 2026-03-09 | 0001193125-26-097582 | EDGAR | 2K words |
| 2026-02-25 | 0001193125-26-068566 | EDGAR | — |
| 2026-01-12 | 0001193125-26-009758 | EDGAR | — |
| 2025-12-18 | 0001193125-25-324796 | EDGAR | — |
| 2025-12-11 | 0001193125-25-315039 | EDGAR | — |
| 2025-11-12 | 0001193125-25-276062 | EDGAR | — |
| 2025-11-03 | 0001193125-25-261722 | EDGAR | — |
| 2025-10-30 | 0001193125-25-258692 | EDGAR | — |
| 2025-10-20 | 0001193125-25-243046 | EDGAR | — |
262 total filings indexed. 230 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001595097 |
| Ticker | CRBP |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.corbuspharma.com |
| Listed | 2014-10-24 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/CRBP (~200 tokens, structured JSON with cryptographic provenance)